OBJECTIVES: As part of a search for new therapeutic opportunities to treat chagasic patients, in vitro efficacy studies were performed to characterize the activity of five novel arylimidamides (AIAs) against Trypanosoma cruzi. METHODS: The trypanocidal effect against T. cruzi was evaluated by light microscopy through the determination of IC₅₀ values. Cytotoxicity was determined by MTT assays against mouse cardiomyocytes. RESULTS: Our data demonstrated the trypanocidal efficacy of these new compounds against bloodstream trypomastigotes and intracellular amastigotes, exhibiting IC₅₀ values ranging from 0.015 to 2.5 and 0.02 to0.2 μM, respectively. One of the compounds, DB745B, was also highly active against a broad panel of isolates, including those naturally resistant to benznidazole. DB745B showed higher in vitro efficacy than the reference drugs used to treat patients (benznidazole IC₅₀= 12.94 μM) and to prevent blood bank infection (gentian violet IC₅₀= 30.6 μM). CONCLUSIONS: AIAs represent promising new chemical entities against T. cruzi and are also potential trypanocidal agents to prevent transfusion-associated Chagas' disease.
OBJECTIVES: As part of a search for new therapeutic opportunities to treat chagasic patients, in vitro efficacy studies were performed to characterize the activity of five novel arylimidamides (AIAs) against Trypanosoma cruzi. METHODS: The trypanocidal effect against T. cruzi was evaluated by light microscopy through the determination of IC₅₀ values. Cytotoxicity was determined by MTT assays against mouse cardiomyocytes. RESULTS: Our data demonstrated the trypanocidal efficacy of these new compounds against bloodstream trypomastigotes and intracellular amastigotes, exhibiting IC₅₀ values ranging from 0.015 to 2.5 and 0.02 to0.2 μM, respectively. One of the compounds, DB745B, was also highly active against a broad panel of isolates, including those naturally resistant to benznidazole. DB745B showed higher in vitro efficacy than the reference drugs used to treat patients (benznidazole IC₅₀= 12.94 μM) and to prevent blood bank infection (gentian violet IC₅₀= 30.6 μM). CONCLUSIONS: AIAs represent promising new chemical entities against T. cruzi and are also potential trypanocidal agents to prevent transfusion-associated Chagas' disease.
Authors: Xiaohua Zhu; Qiang Liu; Sihyung Yang; Toufan Parman; Carol E Green; Jon C Mirsalis; Maria de Nazaré Correia Soeiro; Elen Mello de Souza; Cristiane França da Silva; Denise da Gama Jaen Batista; Chad E Stephens; Moloy Banerjee; Abdelbasset A Farahat; Manoj Munde; W David Wilson; David W Boykin; Michael Zhuo Wang; Karl A Werbovetz Journal: Antimicrob Agents Chemother Date: 2012-04-16 Impact factor: 5.191
Authors: Andrea Angheben; Lucia Boix; Dora Buonfrate; Federico Gobbi; Zeno Bisoffi; Simonetta Pupella; Giorgio Gandini; Giuseppe Aprili Journal: Blood Transfus Date: 2015-10 Impact factor: 3.443
Authors: Julianna Siciliano de Araújo; Cristiane França da Silva; Denise da Gama Jaén Batista; Aline Nefertiti; Ludmila Ferreira de Almeida Fiuza; Cristina Rosa Fonseca-Berzal; Patrícia Bernardino da Silva; Marcos Meuser Batista; Maarten Sijm; Titilola D Kalejaiye; Harry P de Koning; Louis Maes; Geert Jan Sterk; Rob Leurs; Maria de Nazaré Correia Soeiro Journal: Antimicrob Agents Chemother Date: 2020-08-20 Impact factor: 5.191
Authors: F H Guedes-da-Silva; D G J Batista; M B Meuser; K C Demarque; T O Fulco; J S Araújo; P B Da Silva; C F Da Silva; D A Patrick; S M Bakunova; S A Bakunov; R R Tidwell; G M Oliveira; C Britto; O C Moreira; M N C Soeiro Journal: Antimicrob Agents Chemother Date: 2016-03-25 Impact factor: 5.191
Authors: J S De Araújo; C F Da Silva; D G J Batista; P B Da Silva; M B Meuser; C A F Aiub; M F V da Silva; C F Araújo-Lima; M Banerjee; A A Farahat; C E Stephens; A Kumar; D W Boykin; M N C Soeiro Journal: Antimicrob Agents Chemother Date: 2014-03-03 Impact factor: 5.191
Authors: Cristiane França da Silva; Denise da Gama Jaen Batista; Julianna Siciliano De Araújo; Marcos Meuser Batista; Jessica Lionel; Elen Mello de Souza; Erica Ripoll Hammer; Patricia Bernardino da Silva; Maria De Mieri; Michael Adams; Stefanie Zimmermann; Matthias Hamburger; Reto Brun; Wolfgang Schühly; Maria de Nazaré Correia Soeiro Journal: Antimicrob Agents Chemother Date: 2013-08-12 Impact factor: 5.191
Authors: Michelle Schorer; Karim Debache; Fabienne Barna; Thierry Monney; Joachim Müller; David W Boykin; Chad E Stephens; Andrew Hemphill Journal: Int J Parasitol Drugs Drug Resist Date: 2012-04-02 Impact factor: 4.077
Authors: Cristiane França da Silva; Denise da Gama Jaen Batista; Gabriel Melo Oliveira; Elen Mello de Souza; Erica Ripoll Hammer; Patricia Bernardino da Silva; Anissa Daliry; Julianna Siciliano Araujo; Constança Britto; Ana Carolina Mondaine Rodrigues; Zongying Liu; Abdelbasset A Farahat; Arvind Kumar; David W Boykin; Maria de Nazaré Correia Soeiro Journal: PLoS One Date: 2012-01-23 Impact factor: 3.240